期刊文献+

药物中间体α-乙酰基环己酮的合成工艺 被引量:2

Synthesis and Characteriztion of Medicine Intermediates α-Acetylcyclohexanone
下载PDF
导出
摘要 α-乙酰基环己酮是一种重要的医药中间体。环己酮和吗啡啉以有机溶剂甲苯为共沸剂,以对甲苯磺酸为催化剂,进行缩合反应生成烯胺,然后加入缚酸剂三乙胺,滴加乙酰氯和有机溶剂的混合物,烯胺与乙酰氯发生亲核加成反应,生成亚胺正离子,最后加入浓盐酸对亚胺正离子进行水解,生成研究产物2-乙酰基环己酮。产物结构经红外光谱、核磁共振氢谱分析验证与目标化合物的结构一致。该方法经济环保,简单易操作。 α-acetylcyclohexanone is an important pharmaceutical intermediate.With toluene as azeotropic agent and toluene-p-sulfonic acid as catalyst cyclohexanone and morpholine cocondensate,enamine was generated.And then it underwent nucleophillic addition with acetylchloride in presence of deacid reagent triethylamine to yield an imidic cation and finally underwent hydrolysis with concentrated hydrochloric acid to yield the target product α-acetylcyclohexanone.Structure of the compound was confirmed by both IR and NMR spectroscopy.This synthetic method is economical and environmentally benign and operator friendly.
出处 《常州大学学报(自然科学版)》 CAS 2010年第4期24-27,共4页 Journal of Changzhou University:Natural Science Edition
基金 常州大学科技基金项目(ZMF05020022)
关键词 α-乙酰基环己酮 缩合反应 酰基化 α-acetylcyclohexanone condensation acylation
  • 相关文献

参考文献11

  • 1徐正平,朱健华,姚登福.内皮素转换酶——内皮素与动脉粥样硬化关系的研究进展[J].南通大学学报(医学版),2005,25(2):147-150. 被引量:6
  • 2李桂云.内皮素的生物特性及对子宫细胞功能的调节作用[J].国外医学(妇产科学分册),2000,27(4):195-198. 被引量:6
  • 3Jasmin JF,Dupuis J.Evaluation of luminal enothelin conver-ting enzyme activity in the pul monary and coronary circulations. Journal of Cardiovascular Pharmacology . 2004
  • 4Alberola A M,Revert F,Moya A,et al.Intravenous BQ-123and Phosphoramidon reduce ventricular ectopic beats and myocardial infart size in dogs submitted to coronary occlusion and reperfusion. Genpharmacol . 2000
  • 5Nauyen Q T,Cernacek P,Sirois M G,et al.Long-term effects of nonselective endothelin A and B receptor antagonism in postinfarction rat:Importance of timing. Circulation . 2001
  • 6Doggrell S A.The therapeutic potential of endothelin-1re-ceptor antagonists and endothelin-converting enzymeinhibitors onthe cardiovascular system. Expert OpinInvestig Drugs . 2002
  • 7Wu C,Decker E R,George W,et al.Nonpeptideendothelin antagonists in clinical development. Drugs of Today . 2001
  • 8Tirpak R E,Rathke M W.Acylation of ketone silyl enol ethers with acid chloridse. Journal of Organic Chemistry . 1982
  • 9Yang, D,Li, J.-H,Gao, Q,Yah, Y.-L.Lanthanide Triflate-Promoted palladium-Catalyzed Cyclization of Alkenyl -Keto Esters and Amides. Organic Letters . 2003
  • 10ROSS A.Widenhoefer,palladium-catalyzed alkylation of unactivated olefins. Pure and Applied Chemistry . 2004

二级参考文献46

  • 1Suzaki Y, Yosizumi M, Yamashita y. et al. Determination of plasma concentrations of endothelin- 1(1 - 31 ) and endothelin-1 in healthy subjects and patients with Atherosclerosis[J]. J Cardiovuasc Pharmacol, 2003,41 (suppl l ) : s83.
  • 2Maguire J, Kuc RE, Davenport Ap, et al. Vasoconstric-tor activity of novel endothelin peptide, ET- 1 (1-31) in human mammary and coronary arteries invitro[J]. Br J pharmacol.2001,134(6) : 1360.
  • 3Mawatar K, Skakui, Harada N, et al Endothelin-1(1-31)level are increased in atherosclerotic lesions of the thoracic aorta of hypercholesterolemi chamsters [J], Atherosclerosis. 9004,175(2) : 203.
  • 4Kathryn J, Macleod, Rhonda D, et al. Constitutive phosphorylation of Human Endothelin- converting enzyme- 1 Isoforms[J].J Biochem,2002,277 : 46355.
  • 5Muller L, Barret A, Etienne E, et al. Heterodimerization of Endothelin - converting enzyme- 1 Isoforms Regulates the Subcellular Distribtion of this metalloptotease [J].J Biochem,2003,278(1) : 545.
  • 6Ikeda S, Emoto N, Alimsardiono H. et al. Molecular isolation and characterization of novel four subisoforms of ECE-2[J].Biochem Biophys Res Commun. 2002,293(1 ): 421.
  • 7Davenport A, Kul R. Cellular expression of isoforms of endothelin - converting enzyme - 1 and endothelin - converting nzyme - 2 [J]. J Cardiovas Pharmacol , 2000,36 ( 5suppl 1 ) :s12.
  • 8Jasmin JF, Dupuis J. Evaluation of luminal enothelin-converting enzyme activity in the pulmonary and coronary circulations[J].J cardiovasc Pharmacol, 2004,43 ( 1 ) : 21.
  • 9Jasmin JF, Dupuis J. Evaluation of luminal endothelin - con verting enzyme activity in the pulmonary and coronary circulations[J]. J cardiovasc Pharmacol ,2004,43(1) : 21.
  • 10Duru F, Barton M. Thomas F, et al. Endothelin an dcar-diacarrhythmias: do endothelin antagonists have a therapeutic potential as antiarrhythmic drugs? [J].Car Diovasc Res,2001,49 : 272.

共引文献9

同被引文献7

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部